• About
  • Board
  • Expert Index
  • Podcasts
  • News
  • Sign up
  • Contact

Visit

VJHemOnc - Hematological Oncology
  • Home
  • Diseases
    Leukemia
    Lymphoma
    Multiple Myeloma
    Myeloproliferative Neoplasms
    Myelodysplastic Syndromes
    Others
    View all Diseases
  • Trials
    • MUK Nine b
    • TEAMM
    • MUK Seven
    • PERSPECTIVE
    • Hokusai VTE-Cancer Study
    • ZUMA-3
    • UKALL14
    • MEDI4736
    • BMS-936558
    • BRIGHT AML1019
    • View all trials
  • Medicines
    • Levofloxacin
    • Edoxaban
    • AMG 330
    • Glasdegib
    • IMGN779
    • Avapritinib
    • Cirmtuzumab
    • Pegfilgrastim
    • Procarbazine
    • Filanesib
    • View all medicines
  • Topics
    • Disease Biology
    • Pharmacy
    • Surgery
    • Treatment
    • Communication
    • Perspectives
    • Policy
    • Psycho-Oncology
    • Supportive Care
    • Transplantation
    • View all topics
  • Conferences
    • HOPA 2018
    • EBMT 2018
    • iwAL 2018
    • UKONS 2017
    • ASH 2017
    • MPN Advances Day 2017
    • NCRI 2017
    • ESH 2017
    • Myeloma 2017
    • BOPA 2017
    • View upcoming conferences
    • View previous conferences
  • Features
    • About
    • Board
    • Expert Index
    • Podcasts
    • News
    • Sign up
    • Contact
3:58
ZUMA-1: a pivotal trial of CAR T-cells in NHL
Yi Lin
4:35
The use of anticoagulants in cancer-associated venous thromboembolism
Alejandro Lazo-Langner
6:30
GHSD HD18 study: reducing chemotherapy toxicity in advanced stage Hodgkin lymphoma
Peter Borchmann
4:38
Different is better: the fight against leukemia
Michaela Kotrová
7:25
Towards a world without blood disorders
Tony Green
3:42
Trial results of venetoclax plus CHOP therapy with rituximab or obinutuzumab in non-Hodgkin lymphoma
Andrew Zelenetz
2:52
Updated analysis of Phase III trial of idelalisib combined with bendamustine and rituximab in CLL
Andrew Zelenetz
4:28
Erythromer, a nanoscale bio-synthetic artificial red cell
Allan Doctor
6:16
CPX-351 liposome injection vs standard cytarabine and daunorubicin for older high-risk AML patients
Jeffrey Lancet
6:32
Targeted factor VIII delivery in hemophilia with inhibitors
Caroline Hansen
6:57
MRD negative complete remissions following anti-CD22 CAR in relapsed/refractory ALL
Terry J. Fry
5:04
Novel therapies and unique delivery methods to improve treatment for bleeding crises, leukemia
Armand Keating
6:27
Adeno-associated virus mediated gene transfer for hemophilia B
Katherine A. High
5:29
Unmet clinical need: a low-cost, easy-to-use, portable platform for assessment of hemostasis
Evi Stavrou
6:02
EURO-SKI trial: cessation of TKI treatment in CML patients with deep molecular response
François-Xavier Mahon
5:15
Clinical challenges in chronic myeloid leukemia
Mhairi Copland
  • 1
  • 2
  • 3
  • Next
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue
Video channels
  • Chronic Lymphocytic Leukemia
  • Follicular Lymphoma
  • Multiple Myeloma
  • B-Cell Lymphoma
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Diffuse Large B-Cell Lymphoma
  • Chronic Myeloid Leukemia
  • Amyloidosis
  • Hodgkin Lymphoma
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Terms of Use
  • Terms of Use
  • Privacy Policy